🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Theodore R. Levin

Kaiser Permanente

ORCID: 0000-0002-0842-2377
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile
0.267Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Discrepancy in Metabolic Dysfunction–Associated Steatotic Liver Disease Prevalence in a Large Northern California Cohort

Gastro Hep Advances(2025)10.1016/j.gastha.2025.100630
Top 58%
0.267DataRank
Top 58%2 citations

Lue‐Yen Tucker, Varun Saxena, Theodore R. Levin, Luis A. Rodríguez

Papers

Driven by 10 papers — median percentile 42. Top paper: “Impact of a scalable training program on the quality of colonoscopy performance and risk of postcolonoscopy colorectal cancer”.

Impact of a scalable training program on the quality of colonoscopy performance and risk of postcolonoscopy colorectal cancer

Gastrointestinal Endoscopy(2023)10.1016/j.gie.2023.04.2073
N/A
0.360DataRank · unranked
10 citations

Christopher D. Jensen, Jeffrey K. Lee, Theodore R. Levin, Wei Zhao, Joanne E. Schottinger +9 more

Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning Ten Years after a Negative Colonoscopy, among Screen-Eligible Adults 76 to 85 Years Old

Cancer Epidemiology Biomarkers & Prevention(2022)10.1158/1055-9965.epi-22-0581
N/A
0.330DataRank · unranked
8 citations

Rebecca A. Ziebell, Aruna Kamineni, Amanda I. Phipps, Noel S. Weiss, Erica S. Breslau +7 more

Incidence of Serious Complications following Screening Colonoscopy in Adults Ages 76 to 85 Years

Cancer Epidemiology Biomarkers & Prevention(2024)10.1158/1055-9965.epi-24-0551
N/A
0.269DataRank · unranked
5 citations

Laura Ichikawa, Sophie A. Merchant, Ronit R. Dalmat, Rebecca A. Ziebell, Christopher D. Jensen +9 more

Discrepancy in Metabolic Dysfunction–Associated Steatotic Liver Disease Prevalence in a Large Northern California Cohort

Gastro Hep Advances(2025)10.1016/j.gastha.2025.100630
Top 58%
0.267DataRank
Top 58%2 citations

Lue‐Yen Tucker, Varun Saxena, Theodore R. Levin, Luis A. Rodríguez

Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing

Cancer Epidemiology Biomarkers & Prevention(2023)10.1158/1055-9965.epi-23-0507
N/A
0DataRank · unranked
6 citations

Rasmi G. Nair, Celette Sugg Skinner, Caitlin C. Murphy, Eric J. Kim, Cynthia Ortiz +9 more

The effect of using fecal testing after a negative sigmoidoscopy on the risk of death from colorectal cancer

Journal of Medical Screening(2020)10.1177/0969141320921427
N/A
0DataRank · unranked
3 citations

Douglas A. Corley, Christopher D. Jensen, Joanne E. Schottinger, Jeffery K Lee, Nirupa R. Ghai +11 more

Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning One Year after a Negative Fecal Occult Blood Test, among Screen-Eligible 76- to 85-Year-Olds

Cancer Epidemiology Biomarkers & Prevention(2023)10.1158/1055-9965.epi-23-0265
N/A
0DataRank · unranked
2 citations

Rebecca A. Ziebell, Aruna Kamineni, Amanda I. Phipps, Noel S. Weiss, Erica S. Breslau +9 more

Fecal Immunochemical Test Screening and Risk of Colorectal Cancer Death

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.23671
N/A
0DataRank · unranked
39 citations

Douglas A. Corley, Christopher D. Jensen, Theodore R. Levin, Nirupa R. Ghai, Kimberly L. Cannavale +8 more

What Is Organized Screening and What Is Its Value?

Gastrointestinal Endoscopy Clinics of North America(2020)10.1016/j.giec.2020.02.002
N/A
0DataRank · unranked
32 citations

Theodore R. Levin, Jason A. Dominitz

Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention–sponsored Summit

CA A Cancer Journal for Clinicians(2020)10.3322/caac.21615
N/A
0DataRank · unranked
121 citations

Gloria D. Coronado, Keith Argenbright, Alison T. Brenner, Sheila F. Castañeda, Jason A. Dominitz +9 more